Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NIH Needs To Reconcile Differing Clinical Trial Registry Expectations

This article was originally published in The Gray Sheet

Executive Summary

The National Institutes of Health is trying to reconcile new clinical trial registry requirements for medical devices under the recently enacted FDA Amendments Act with the existing policy of leading medical journal editors

You may also be interested in...



ClinicalTrials.gov Requirements Continue To Baffle Firms And Feds Alike

Device companies are not the only ones tripped up by the new ClinicalTrials.gov trial registration requirements, as FDA, NIH and others struggle to define what is and is not subject to the law

ClinicalTrials.gov Requirements Continue To Baffle Firms And Feds Alike

Device companies are not the only ones tripped up by the new ClinicalTrials.gov trial registration requirements, as FDA, NIH and others struggle to define what is and is not subject to the law

Firms Should Establish Internal Policies For Trial Registry Requirements

Companies should develop internal policies in coordination with FDA about how they are going to comply with new clinical trial registration requirements until more formal rulemaking and guidance are available, according to Rebecca Williams, assistant director of the National Institutes of Health 1ClinicalTrials.gov

Latest News
See All
UsernamePublicRestriction

Register

MT025502

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel